Global New Generation Implants
Global New Generation Implants

New Generation Implants Comprehensive Study by Application (Orthopedic Implants, Cardiovascular Implants, Ocular Implants, Dental Implants), Raw Material (Metals and Alloys, Ceramics, Polymers, Biologicals, Others) Players and Region - Global Market Outlook to 2026

New Generation Implants Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026  

Oct 2021 Edition 234 Pages 210 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Global New Generation Implants Market Overview:
Medical implants are devices that are inserted or grafted into the body of a patient to serve as a part or entire organ. An implant, according to the US Food and Drug Administration, is a device or tissue that can be placed on the surface or inside the body. These devices help to support existing organs, replace them, or replace missing portions. These types of implants are also being used by the younger generation as a result of lifestyle changes. Increased physical inactivity, obesity, and fast food intake are all factors that contribute to the development of such diseases and, as a result, boost the demand for implant devices.

Growth Drivers
  • Growing cases of chronic diseases and the increasing geriatric population
  • Increasing geriatric population suffering from bone fractures

Roadblocks
  • High cost of implants and surgery

Opportunities
  • Rising demand for new generation implants in developing countries
  • Advanced product development

Challenges
  • The exceptionally high corrosion rate in the physiological environment


Competitive Landscape:
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies.
Some of the key players profiled in the report are Abbott Laboratories (United States), Arthrex (United States), Biotronik SE & Co. KG (Germany), Boston Scientific Corporation (United States), C. R. BARD, INC. (United States), Danaher Corporation (United States), Dentsply Sirona (United States), Edwards Lifesciences Corporation (United States), Globus Medical Inc. (United States) and Integer Holdings Corporation (United States). Additionally, following companies can also be profiled that are part of our coverage like Integra LifeSciences Corporation (United States), Institut Straumann AG (Switzerland) and LifeNet Health, Inc. (United States). Analyst at AMA Research see United States Players to retain maximum share of Global New Generation Implants market by 2026. Considering Market by Raw Material, the sub-segment i.e. Metals and Alloys will boost the New Generation Implants market.

In 2018, Straumann announced the launch of several new products, including a new two-piece ceramic implant and a mini-implant system.

What Can be Explored with the New Generation Implants Market Study
 Gain Market Understanding
 Identify Growth Opportunities
 Analyze and Measure the Global New Generation Implants Market by Identifying Investment across various Industry Verticals
 Understand the Trends that will drive Future Changes in New Generation Implants
 Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global New Generation Implants market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in New Generation Implants market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes New Entrants and Investors, New Generation Implants Provider, Venture Capitalists, Government Bodies, Corporate Entities, Government and Private Research Organizations and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.

Frequently Asked Questions (FAQ):

1. What is the growth rate predicted for the Global New Generation Implants Market?
The New Generation Implants market is expected to see a CAGR of % during projected year 2020 to 2026.

2. Who are the top performing companies in New Generation Implants Market?
Top performing companies in the Global New Generation Implants market are Abbott Laboratories (United States), Arthrex (United States), Biotronik SE & Co. KG (Germany), Boston Scientific Corporation (United States), C. R. BARD, INC. (United States), Danaher Corporation (United States), Dentsply Sirona (United States), Edwards Lifesciences Corporation (United States), Globus Medical Inc. (United States) and Integer Holdings Corporation (United States), to name a few.

3. What trending factors would impact New Generation Implants Market growth most?
"Increase in research and development for the discovery of new products" is seen as one of major influencing trends for New Generation Implants Market during projected period 2020-2026.

Report Objectives / Segmentation Covered
By Application
  • Orthopedic Implants
  • Cardiovascular Implants
  • Ocular Implants
  • Dental Implants
By Raw Material
  • Metals and Alloys
  • Ceramics
  • Polymers
  • Biologicals
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing cases of chronic diseases and the increasing geriatric population
      • 3.2.2. Increasing geriatric population suffering from bone fractures
    • 3.3. Market Challenges
      • 3.3.1. The exceptionally high corrosion rate in the physiological environment
    • 3.4. Market Trends
      • 3.4.1. Increase in research and development for the discovery of new products
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global New Generation Implants, by Application, Raw Material and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global New Generation Implants (Value)
      • 5.2.1. Global New Generation Implants by: Application (Value)
        • 5.2.1.1. Orthopedic Implants
        • 5.2.1.2. Cardiovascular Implants
        • 5.2.1.3. Ocular Implants
        • 5.2.1.4. Dental Implants
      • 5.2.2. Global New Generation Implants by: Raw Material (Value)
        • 5.2.2.1. Metals and Alloys
        • 5.2.2.2. Ceramics
        • 5.2.2.3. Polymers
        • 5.2.2.4. Biologicals
        • 5.2.2.5. Others
      • 5.2.3. Global New Generation Implants Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
  • 6. New Generation Implants: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Abbott Laboratories (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Arthrex (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Biotronik SE & Co. KG (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Boston Scientific Corporation (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. C. R. BARD, INC. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Danaher Corporation (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Dentsply Sirona (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Edwards Lifesciences Corporation (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Globus Medical Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Integer Holdings Corporation (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global New Generation Implants Sale, by Application, Raw Material and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global New Generation Implants (Value)
      • 7.2.1. Global New Generation Implants by: Application (Value)
        • 7.2.1.1. Orthopedic Implants
        • 7.2.1.2. Cardiovascular Implants
        • 7.2.1.3. Ocular Implants
        • 7.2.1.4. Dental Implants
      • 7.2.2. Global New Generation Implants by: Raw Material (Value)
        • 7.2.2.1. Metals and Alloys
        • 7.2.2.2. Ceramics
        • 7.2.2.3. Polymers
        • 7.2.2.4. Biologicals
        • 7.2.2.5. Others
      • 7.2.3. Global New Generation Implants Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. New Generation Implants: by Application(USD Million)
  • Table 2. New Generation Implants Orthopedic Implants , by Region USD Million (2015-2020)
  • Table 3. New Generation Implants Cardiovascular Implants , by Region USD Million (2015-2020)
  • Table 4. New Generation Implants Ocular Implants , by Region USD Million (2015-2020)
  • Table 5. New Generation Implants Dental Implants , by Region USD Million (2015-2020)
  • Table 6. New Generation Implants: by Raw Material(USD Million)
  • Table 7. New Generation Implants Metals and Alloys , by Region USD Million (2015-2020)
  • Table 8. New Generation Implants Ceramics , by Region USD Million (2015-2020)
  • Table 9. New Generation Implants Polymers , by Region USD Million (2015-2020)
  • Table 10. New Generation Implants Biologicals , by Region USD Million (2015-2020)
  • Table 11. New Generation Implants Others , by Region USD Million (2015-2020)
  • Table 12. South America New Generation Implants, by Country USD Million (2015-2020)
  • Table 13. South America New Generation Implants, by Application USD Million (2015-2020)
  • Table 14. South America New Generation Implants, by Raw Material USD Million (2015-2020)
  • Table 15. Brazil New Generation Implants, by Application USD Million (2015-2020)
  • Table 16. Brazil New Generation Implants, by Raw Material USD Million (2015-2020)
  • Table 17. Argentina New Generation Implants, by Application USD Million (2015-2020)
  • Table 18. Argentina New Generation Implants, by Raw Material USD Million (2015-2020)
  • Table 19. Rest of South America New Generation Implants, by Application USD Million (2015-2020)
  • Table 20. Rest of South America New Generation Implants, by Raw Material USD Million (2015-2020)
  • Table 21. Asia Pacific New Generation Implants, by Country USD Million (2015-2020)
  • Table 22. Asia Pacific New Generation Implants, by Application USD Million (2015-2020)
  • Table 23. Asia Pacific New Generation Implants, by Raw Material USD Million (2015-2020)
  • Table 24. China New Generation Implants, by Application USD Million (2015-2020)
  • Table 25. China New Generation Implants, by Raw Material USD Million (2015-2020)
  • Table 26. Japan New Generation Implants, by Application USD Million (2015-2020)
  • Table 27. Japan New Generation Implants, by Raw Material USD Million (2015-2020)
  • Table 28. India New Generation Implants, by Application USD Million (2015-2020)
  • Table 29. India New Generation Implants, by Raw Material USD Million (2015-2020)
  • Table 30. South Korea New Generation Implants, by Application USD Million (2015-2020)
  • Table 31. South Korea New Generation Implants, by Raw Material USD Million (2015-2020)
  • Table 32. Taiwan New Generation Implants, by Application USD Million (2015-2020)
  • Table 33. Taiwan New Generation Implants, by Raw Material USD Million (2015-2020)
  • Table 34. Australia New Generation Implants, by Application USD Million (2015-2020)
  • Table 35. Australia New Generation Implants, by Raw Material USD Million (2015-2020)
  • Table 36. Rest of Asia-Pacific New Generation Implants, by Application USD Million (2015-2020)
  • Table 37. Rest of Asia-Pacific New Generation Implants, by Raw Material USD Million (2015-2020)
  • Table 38. Europe New Generation Implants, by Country USD Million (2015-2020)
  • Table 39. Europe New Generation Implants, by Application USD Million (2015-2020)
  • Table 40. Europe New Generation Implants, by Raw Material USD Million (2015-2020)
  • Table 41. Germany New Generation Implants, by Application USD Million (2015-2020)
  • Table 42. Germany New Generation Implants, by Raw Material USD Million (2015-2020)
  • Table 43. France New Generation Implants, by Application USD Million (2015-2020)
  • Table 44. France New Generation Implants, by Raw Material USD Million (2015-2020)
  • Table 45. Italy New Generation Implants, by Application USD Million (2015-2020)
  • Table 46. Italy New Generation Implants, by Raw Material USD Million (2015-2020)
  • Table 47. United Kingdom New Generation Implants, by Application USD Million (2015-2020)
  • Table 48. United Kingdom New Generation Implants, by Raw Material USD Million (2015-2020)
  • Table 49. Netherlands New Generation Implants, by Application USD Million (2015-2020)
  • Table 50. Netherlands New Generation Implants, by Raw Material USD Million (2015-2020)
  • Table 51. Rest of Europe New Generation Implants, by Application USD Million (2015-2020)
  • Table 52. Rest of Europe New Generation Implants, by Raw Material USD Million (2015-2020)
  • Table 53. MEA New Generation Implants, by Country USD Million (2015-2020)
  • Table 54. MEA New Generation Implants, by Application USD Million (2015-2020)
  • Table 55. MEA New Generation Implants, by Raw Material USD Million (2015-2020)
  • Table 56. Middle East New Generation Implants, by Application USD Million (2015-2020)
  • Table 57. Middle East New Generation Implants, by Raw Material USD Million (2015-2020)
  • Table 58. Africa New Generation Implants, by Application USD Million (2015-2020)
  • Table 59. Africa New Generation Implants, by Raw Material USD Million (2015-2020)
  • Table 60. North America New Generation Implants, by Country USD Million (2015-2020)
  • Table 61. North America New Generation Implants, by Application USD Million (2015-2020)
  • Table 62. North America New Generation Implants, by Raw Material USD Million (2015-2020)
  • Table 63. United States New Generation Implants, by Application USD Million (2015-2020)
  • Table 64. United States New Generation Implants, by Raw Material USD Million (2015-2020)
  • Table 65. Canada New Generation Implants, by Application USD Million (2015-2020)
  • Table 66. Canada New Generation Implants, by Raw Material USD Million (2015-2020)
  • Table 67. Mexico New Generation Implants, by Application USD Million (2015-2020)
  • Table 68. Mexico New Generation Implants, by Raw Material USD Million (2015-2020)
  • Table 69. Company Basic Information, Sales Area and Its Competitors
  • Table 70. Company Basic Information, Sales Area and Its Competitors
  • Table 71. Company Basic Information, Sales Area and Its Competitors
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. Company Basic Information, Sales Area and Its Competitors
  • Table 74. Company Basic Information, Sales Area and Its Competitors
  • Table 75. Company Basic Information, Sales Area and Its Competitors
  • Table 76. Company Basic Information, Sales Area and Its Competitors
  • Table 77. Company Basic Information, Sales Area and Its Competitors
  • Table 78. Company Basic Information, Sales Area and Its Competitors
  • Table 79. New Generation Implants: by Application(USD Million)
  • Table 80. New Generation Implants Orthopedic Implants , by Region USD Million (2021-2026)
  • Table 81. New Generation Implants Cardiovascular Implants , by Region USD Million (2021-2026)
  • Table 82. New Generation Implants Ocular Implants , by Region USD Million (2021-2026)
  • Table 83. New Generation Implants Dental Implants , by Region USD Million (2021-2026)
  • Table 84. New Generation Implants: by Raw Material(USD Million)
  • Table 85. New Generation Implants Metals and Alloys , by Region USD Million (2021-2026)
  • Table 86. New Generation Implants Ceramics , by Region USD Million (2021-2026)
  • Table 87. New Generation Implants Polymers , by Region USD Million (2021-2026)
  • Table 88. New Generation Implants Biologicals , by Region USD Million (2021-2026)
  • Table 89. New Generation Implants Others , by Region USD Million (2021-2026)
  • Table 90. South America New Generation Implants, by Country USD Million (2021-2026)
  • Table 91. South America New Generation Implants, by Application USD Million (2021-2026)
  • Table 92. South America New Generation Implants, by Raw Material USD Million (2021-2026)
  • Table 93. Brazil New Generation Implants, by Application USD Million (2021-2026)
  • Table 94. Brazil New Generation Implants, by Raw Material USD Million (2021-2026)
  • Table 95. Argentina New Generation Implants, by Application USD Million (2021-2026)
  • Table 96. Argentina New Generation Implants, by Raw Material USD Million (2021-2026)
  • Table 97. Rest of South America New Generation Implants, by Application USD Million (2021-2026)
  • Table 98. Rest of South America New Generation Implants, by Raw Material USD Million (2021-2026)
  • Table 99. Asia Pacific New Generation Implants, by Country USD Million (2021-2026)
  • Table 100. Asia Pacific New Generation Implants, by Application USD Million (2021-2026)
  • Table 101. Asia Pacific New Generation Implants, by Raw Material USD Million (2021-2026)
  • Table 102. China New Generation Implants, by Application USD Million (2021-2026)
  • Table 103. China New Generation Implants, by Raw Material USD Million (2021-2026)
  • Table 104. Japan New Generation Implants, by Application USD Million (2021-2026)
  • Table 105. Japan New Generation Implants, by Raw Material USD Million (2021-2026)
  • Table 106. India New Generation Implants, by Application USD Million (2021-2026)
  • Table 107. India New Generation Implants, by Raw Material USD Million (2021-2026)
  • Table 108. South Korea New Generation Implants, by Application USD Million (2021-2026)
  • Table 109. South Korea New Generation Implants, by Raw Material USD Million (2021-2026)
  • Table 110. Taiwan New Generation Implants, by Application USD Million (2021-2026)
  • Table 111. Taiwan New Generation Implants, by Raw Material USD Million (2021-2026)
  • Table 112. Australia New Generation Implants, by Application USD Million (2021-2026)
  • Table 113. Australia New Generation Implants, by Raw Material USD Million (2021-2026)
  • Table 114. Rest of Asia-Pacific New Generation Implants, by Application USD Million (2021-2026)
  • Table 115. Rest of Asia-Pacific New Generation Implants, by Raw Material USD Million (2021-2026)
  • Table 116. Europe New Generation Implants, by Country USD Million (2021-2026)
  • Table 117. Europe New Generation Implants, by Application USD Million (2021-2026)
  • Table 118. Europe New Generation Implants, by Raw Material USD Million (2021-2026)
  • Table 119. Germany New Generation Implants, by Application USD Million (2021-2026)
  • Table 120. Germany New Generation Implants, by Raw Material USD Million (2021-2026)
  • Table 121. France New Generation Implants, by Application USD Million (2021-2026)
  • Table 122. France New Generation Implants, by Raw Material USD Million (2021-2026)
  • Table 123. Italy New Generation Implants, by Application USD Million (2021-2026)
  • Table 124. Italy New Generation Implants, by Raw Material USD Million (2021-2026)
  • Table 125. United Kingdom New Generation Implants, by Application USD Million (2021-2026)
  • Table 126. United Kingdom New Generation Implants, by Raw Material USD Million (2021-2026)
  • Table 127. Netherlands New Generation Implants, by Application USD Million (2021-2026)
  • Table 128. Netherlands New Generation Implants, by Raw Material USD Million (2021-2026)
  • Table 129. Rest of Europe New Generation Implants, by Application USD Million (2021-2026)
  • Table 130. Rest of Europe New Generation Implants, by Raw Material USD Million (2021-2026)
  • Table 131. MEA New Generation Implants, by Country USD Million (2021-2026)
  • Table 132. MEA New Generation Implants, by Application USD Million (2021-2026)
  • Table 133. MEA New Generation Implants, by Raw Material USD Million (2021-2026)
  • Table 134. Middle East New Generation Implants, by Application USD Million (2021-2026)
  • Table 135. Middle East New Generation Implants, by Raw Material USD Million (2021-2026)
  • Table 136. Africa New Generation Implants, by Application USD Million (2021-2026)
  • Table 137. Africa New Generation Implants, by Raw Material USD Million (2021-2026)
  • Table 138. North America New Generation Implants, by Country USD Million (2021-2026)
  • Table 139. North America New Generation Implants, by Application USD Million (2021-2026)
  • Table 140. North America New Generation Implants, by Raw Material USD Million (2021-2026)
  • Table 141. United States New Generation Implants, by Application USD Million (2021-2026)
  • Table 142. United States New Generation Implants, by Raw Material USD Million (2021-2026)
  • Table 143. Canada New Generation Implants, by Application USD Million (2021-2026)
  • Table 144. Canada New Generation Implants, by Raw Material USD Million (2021-2026)
  • Table 145. Mexico New Generation Implants, by Application USD Million (2021-2026)
  • Table 146. Mexico New Generation Implants, by Raw Material USD Million (2021-2026)
  • Table 147. Research Programs/Design for This Report
  • Table 148. Key Data Information from Secondary Sources
  • Table 149. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global New Generation Implants: by Application USD Million (2015-2020)
  • Figure 5. Global New Generation Implants: by Raw Material USD Million (2015-2020)
  • Figure 6. South America New Generation Implants Share (%), by Country
  • Figure 7. Asia Pacific New Generation Implants Share (%), by Country
  • Figure 8. Europe New Generation Implants Share (%), by Country
  • Figure 9. MEA New Generation Implants Share (%), by Country
  • Figure 10. North America New Generation Implants Share (%), by Country
  • Figure 11. Global New Generation Implants share by Players 2020 (%)
  • Figure 12. Global New Generation Implants share by Players (Top 3) 2020(%)
  • Figure 13. Global New Generation Implants share by Players (Top 5) 2020(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 16. Abbott Laboratories (United States) Revenue: by Geography 2020
  • Figure 17. Arthrex (United States) Revenue, Net Income and Gross profit
  • Figure 18. Arthrex (United States) Revenue: by Geography 2020
  • Figure 19. Biotronik SE & Co. KG (Germany) Revenue, Net Income and Gross profit
  • Figure 20. Biotronik SE & Co. KG (Germany) Revenue: by Geography 2020
  • Figure 21. Boston Scientific Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 22. Boston Scientific Corporation (United States) Revenue: by Geography 2020
  • Figure 23. C. R. BARD, INC. (United States) Revenue, Net Income and Gross profit
  • Figure 24. C. R. BARD, INC. (United States) Revenue: by Geography 2020
  • Figure 25. Danaher Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 26. Danaher Corporation (United States) Revenue: by Geography 2020
  • Figure 27. Dentsply Sirona (United States) Revenue, Net Income and Gross profit
  • Figure 28. Dentsply Sirona (United States) Revenue: by Geography 2020
  • Figure 29. Edwards Lifesciences Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 30. Edwards Lifesciences Corporation (United States) Revenue: by Geography 2020
  • Figure 31. Globus Medical Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 32. Globus Medical Inc. (United States) Revenue: by Geography 2020
  • Figure 33. Integer Holdings Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 34. Integer Holdings Corporation (United States) Revenue: by Geography 2020
  • Figure 35. Global New Generation Implants: by Application USD Million (2021-2026)
  • Figure 36. Global New Generation Implants: by Raw Material USD Million (2021-2026)
  • Figure 37. South America New Generation Implants Share (%), by Country
  • Figure 38. Asia Pacific New Generation Implants Share (%), by Country
  • Figure 39. Europe New Generation Implants Share (%), by Country
  • Figure 40. MEA New Generation Implants Share (%), by Country
  • Figure 41. North America New Generation Implants Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Abbott Laboratories (United States)
  • Arthrex (United States)
  • Biotronik SE & Co. KG (Germany)
  • Boston Scientific Corporation (United States)
  • C. R. BARD, INC. (United States)
  • Danaher Corporation (United States)
  • Dentsply Sirona (United States)
  • Edwards Lifesciences Corporation (United States)
  • Globus Medical Inc. (United States)
  • Integer Holdings Corporation (United States)
Additional players considered in the study are as follows:
Integra LifeSciences Corporation (United States) , Institut Straumann AG (Switzerland) , LifeNet Health, Inc. (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation